feed,title,long_url,short_url
BioRxiv,Engineering customized viral receptors for various coronaviruses,https://biorxiv.org/cgi/content/short/2024.03.03.583237v1?rss=1,https://da.gd/GtFHl
BioRxiv,Immunogenicity and safety of a live-attenuated SARS-CoV-2 vaccine candidate based on multiple attenuation mechanisms,https://biorxiv.org/cgi/content/short/2024.03.03.582873v1?rss=1,https://da.gd/8Lqr47
BioRxiv,Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate AVX/COVID-12 Activates T Cells and Is Recognized by Antibodies from COVID-19 Patients and Vaccinated,https://biorxiv.org/cgi/content/short/2024.03.01.582987v1?rss=1,https://da.gd/rYxw5V
